Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C

Aim of the study. To compare efficacy and safety of Algeron 1.5 and 2.0 μg/kg with PegIntron in combination with ribavirin in the treatment of chronic hepatitis C and to determine therapeutic dose of Algeron.Materials and Methods. 150 adult treatment-naive patients with HCV (all genotypes)were rando...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Mayevskaya, O. O. Znoyko, E. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Format:	Article
Language:	Russian
Published:	Gastro LLC 2013-03-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	chronic hepatitis c treatment cepeginterferon alfa-2b algeron
Online Access:	https://www.gastro-j.ru/jour/article/view/1183
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment of chronic hepatitis C by cepeginterferon alpha-2b in combination to ribavirin
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

Experimental investigation of the mechanical properties of Alfas stone
by: Konstas N. Kaklis, et al.
Published: (2017-04-01)

Efecto del ácido alfa lipoico sobre la peroxidación no enzimática en mitocondrias de corazón y cerebro de rata
by: M. Marmunti, et al.
Published: (2021-01-01)

Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
by: Nayana Hitesh Patel, et al.
Published: (2023-04-01)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
by: R. Rodríguez-Lojo, et al.
Published: (2010-01-01)

Ductus Venosus Doppler S/D Value Adjusted Alfa Fetoprotein Levels to Decrease False Positive Rates
by: Alptekin Tosun, et al.
Published: (2013-12-01)

Experimental and Numerical Analyses of Alfa/Polyester Composite Under Three-Point Bending
by: Mokhtar Belkacem, et al.
Published: (2025-04-01)

Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.
by: Leslie Pérez Ruiz, et al.
Published: (2007-12-01)

De alfa a omega: Estimación de la confiabilidad ordinal. Una guía práctica
by: Nicolás Vizioli, et al.
Published: (2022-12-01)

Pokolenie Alfa w szkole. Działania projektowo-wdrożeniowe z wykorzystaniem ICT
by: Eunika Baron-Polańczyk, et al.
Published: (2022-12-01)

Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis
by: Safak Kaya, et al.
Published: (2015-01-01)

ALFA e BETO: como avaliar leitura e escrita na Educação Infantil?
by: Magna do Carmo Silva, et al.
Published: (2020-05-01)

Pre-failure indicators detected by Acoustic Emission: Alfas stone, cement-mortar and cement-paste specimens under 3-point bending
by: Stavros K. Kourkoulis, et al.
Published: (2017-04-01)

Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC
by: Christian Rolfo, MD, PhD, et al.
Published: (2025-01-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2
by: Naota Taura, et al.
Published: (2012-01-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Assessing the effectiveness of the SOLIO Alfa Cure Plus device in treating low back pain: a randomized controlled study
by: Hadari Yotam, et al.
Published: (2025-01-01)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
by: Amit Chopra, et al.
Published: (2015-01-01)

Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy
by: Eric M Yoshida, et al.
Published: (2009-01-01)

Análisis en la Policía Nacional sobre el estilo de liderazgo a nivel directivo, en atención a las nuevas generaciones
by: Luz Dianelis Avilés-Regino, et al.
Published: (2025-01-01)

Effect of In Vitro Ruminal pH on Zearalenone Degradation and Interaction with Other Mycotoxins in a Static Gastrointestinal Model
by: Rimvydas Falkauskas, et al.
Published: (2024-12-01)

Rare Form of Erdheim-Chester Disease Presenting with Isolated Central Skeletal Lesions Treated with a Combination of Alfa-Interferon and Zoledronic Acid
by: E. N. Bulycheva, et al.
Published: (2015-01-01)

Ischemic Colitis During Pegylated Interferon-Alpha and Ribavirin Therapy for Chronic Hepatitis C
by: Yvette Leung, et al.
Published: (2006-01-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy
by: Bassem Refaat, et al.
Published: (2015-01-01)

Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child
by: Takeshi Endo, et al.
Published: (2012-01-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
by: Alaa Awad Taha, et al.
Published: (2010-01-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy
by: Mohamed Babatin, et al.
Published: (2005-01-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

“Eficacia del Neurofeedback en el Trastorno de Estrés Postraumático en población adulta. Una revisión sistemática”.
by: Adriana Jiménez-Muro Franco, et al.
Published: (2018-01-01)

Expresión de HIF-1α en el frente invasivo del carcinoma de células escamosas orales y su relación con la transición epitetelio-mesénquima
by: Felipe Martins Silveira, et al.
Published: (2024-12-01)

Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis
by: Işıl Peker, et al.
Published: (2024-12-01)

Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
by: MV Chandrakanth, et al.
Published: (2025-01-01)

Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats
by: Xiaohan Cao, et al.
Published: (2014-01-01)

Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study
by: V. T. Ivashkin, et al.
Published: (2014-07-01)

The algorythm of viral hepatites B and C diagnostics and treatment
by: N. D. Yuschuk, et al.
Published: (2010-12-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)